Sina Djali is a Senior Director at The Janssen Pharmaceutical Companies of Johnson & Johnson, with over 25 years of experience in drug and clinical development. He specializes in integrated data analytics, risk management, and clinical operations, and holds degrees from Harvard Business Analytics Program and the University of Pennsylvania.
He has a keen interest in leadership, believing true leaders support their teams through challenges rather than assigning blame. He also follows developments in AI, advocating for its use as a supportive tool rather than a replacement for human decision-making, particularly concerning its effects on cognitive function.
He has developed a data-driven Quality Management System to manage compliance risk in clinical research.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.